- Report
- July 2024
- 237 Pages
Global
From €3276EUR$3,600USD£2,809GBP
- Report
- January 2025
Global
From €6826EUR$7,500USD£5,852GBP
- Report
- April 2025
- 271 Pages
Global
From €6366EUR$6,995USD£5,458GBP
- Newsletter
- April 2025
Global
€2726EUR$2,995USD£2,337GBP
- Report
- March 2025
- 138 Pages
Global
From €3973EUR$4,365USD£3,406GBP
€4414EUR$4,850USD£3,784GBP
- Report
- February 2025
- 130 Pages
Global
From €3973EUR$4,365USD£3,406GBP
€4414EUR$4,850USD£3,784GBP
- Report
- February 2025
- 329 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- February 2025
- 408 Pages
Global
From €3686EUR$4,050USD£3,160GBP
- Report
- September 2024
- 255 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- September 2024
- 97 Pages
Global
From €2685EUR$2,950USD£2,302GBP
- Report
- July 2024
Global
€11376EUR$12,500USD£9,753GBP
- Report
- July 2024
- 110 Pages
Global
From €2685EUR$2,950USD£2,302GBP
- Report
- July 2024
- 221 Pages
Global
From €4505EUR$4,950USD£3,862GBP
- Report
- July 2024
- 180 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- May 2024
- 257 Pages
Global
From €4505EUR$4,950USD£3,862GBP
- Report
- May 2024
- 128 Pages
Global
From €2685EUR$2,950USD£2,302GBP
- Report
- May 2024
- 250 Pages
Global
From €4546EUR$4,995USD£3,897GBP
- Report
- September 2024
- 75 Pages
Asia Pacific
From €569EUR$625USD£488GBP
€1138EUR$1,250USD£975GBP
- Report
- July 2024
- 87 Pages
Europe
From €2002EUR$2,200USD£1,716GBP
- Report
- April 2024
- 125 Pages
Europe
From €2002EUR$2,200USD£1,716GBP

The Biotechnology market has been affected by the pandemic in a variety of ways. Companies in the sector have had to adjust their operations to meet the demands of the new environment. Many have shifted their focus to developing treatments and vaccines for the virus, while others have had to pivot their operations to meet the needs of the changing market. Companies have also had to adjust their supply chains to ensure the safety of their products and services.
The pandemic has also had an impact on the financial performance of biotechnology companies. Many have seen their stock prices decline due to the uncertainty of the market. Additionally, the pandemic has caused a decrease in research and development spending, as well as a decrease in venture capital investments.
Notable companies in the biotechnology market include Gilead Sciences, Moderna, Regeneron Pharmaceuticals, and Novavax. These companies have all been involved in the development of treatments and vaccines for the virus. Additionally, they have all seen their stock prices increase due to the pandemic. Show Less Read more